RxDoctor Payments Data

Timothy Franklin

Family Medicine · Columbus, GANPI 1114586096

Payments from drug & device makers

$5,784in general payments, 2019–2025

Across 281 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$929
  • Boehringer Ingelheim$830
  • Lilly USA, LLC$766
  • Novo Nordisk$603
  • GSK$478
  • Astellas Pharma US Inc$372
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$5,784100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,784 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$46,776
Medicare patients
393
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$52,429
Breztri AerosphereBudesonide/Glycopyr/Formoterol45$32,385
JardianceEmpagliflozin16$15,641
LinzessLinaclotide14$11,472
Gabapentin55$897
Methylprednisolone119$719
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst47$643
Fluticasone Propionate62$597
Atorvastatin Calcium49$548
Irbesartan22$471
Albuterol Sulfate HfaAlbuterol Sulfate22$387
Omeprazole34$386
Diclofenac Sodium28$383
Amlodipine Besylate78$345
Ondansetron OdtOndansetron15$341

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$478$52,42958 claims
AstraZenecaBreztri Aerosphere$929$32,38545 claims
Boehringer IngelheimJardiance$830$15,64116 claims
AbbVieLinzess$105$11,47214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →